IDiyas

For the Inventor, By the Inventor

San Diego, CA, United States of America

Michael J Melnick

USPTO Granted Patents = 13

Average Co-Inventor Count = 6.0

ph-index = 7

Forward Citations = 202(Granted Patents)


Location History:

  • San Diego, CA (US) (1998 - 2005)
  • Ann Arbor, MI (US) (2002 - 2007)

Company Filing History:

goldMedal12 out of 174 
 
Agouron Pharmaceuticals, Inc.
 patents
silverMedal3 out of 932 
 
Syntex (u.s.a.) Inc.
 patents
bronzeMedal1 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1998-2007

Loading Chart...
13 patents (USPTO):Explore Patents
1. 7179918 - HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis (2007-02-20),
2. 6953858 - HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis (2005-10-11),
3. 6849732 - Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation (2005-02-01),
4. 6774243 - Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates (2004-08-10),
5. 6500948 - Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof (2002-12-31),
6. 6376506 - Sulfamide-metalloprotease inhibitors (2002-04-23),
7. 6355807 - Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates (2002-03-12),
8. 6153757 - Metalloproteinase inhibitors and intermediates useful for their (2000-11-28),
9. 6143744 - Sulfamide-metalloprotease inhibitors (2000-11-07),
10. 6130220 - Sulfamide-metalloprotease inhibitors (2000-10-10),
11. 5998412 - Sulfamide-metalloprotease inhibitors (1999-12-07),
12. 5863950 - HIV protease inhibitors (1999-01-26),
13. 5753653 - Metalloproteinase inhibitors, pharmaceutical compositions containing (1998-05-19),

Title: Michael J Melnick: Innovator in HIV Research

Introduction

Michael J Melnick is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of pharmaceutical sciences. With a total of 13 patents to his name, Melnick has focused his research on developing innovative solutions for treating HIV infections. His work has had a profound impact on the medical community and the lives of those affected by the virus.

Latest Patents

Melnick's latest patents include groundbreaking HIV protease inhibitors and compositions that contain these compounds. These inventions are designed to inhibit or block the biological activity of the HIV protease, which is crucial for the virus's replication. The compounds he has developed, along with the pharmaceutical compositions containing them, are particularly useful for treating patients infected with the HIV virus. Additionally, Melnick has described intermediates and synthetic methods for preparing these compounds, further advancing the field of HIV treatment.

Career Highlights

Throughout his career, Melnick has worked with notable companies such as Agouron Pharmaceuticals, Inc. and Syntex (U.S.A.) Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant advancements in HIV research.

Collaborations

Melnick has collaborated with esteemed colleagues, including Steven Lee Bender and Raymond Dagnino, Jr. These partnerships have fostered a collaborative environment that has led to innovative breakthroughs in the development of HIV treatments.

Conclusion

Michael J Melnick's contributions to HIV research through his patents and collaborations have made a lasting impact on the medical field. His dedication to innovation continues to inspire advancements in the treatment of HIV infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…